• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Enfusion Inc.

    3/3/25 4:11:13 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001813901
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Enfusion, Inc.
    SEC File Number
    001-40949
    Address of Issuer
    125 SOUTH CLARK STREET, SUITE 750
    CHICAGO
    ILLINOIS
    60603
    Phone
    (312) 253-9800
    Name of Person for Whose Account the Securities are To Be Sold
    Herring Bradley
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Class A
    Fidelity Brokerage Services LLC
    900 Salem Street
    Smithfield � RI � 02917
    153317600.8312857083803/03/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Class A02/28/2025Restricted Stock VestingIssuerCheckbox not checked153302/28/2025Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Bradley Herring
    125 South Clark Street
    Suite 750
    Chicago � IL � 60603
    Class A12/20/202424443259416.00
    Bradley Herring
    125 South Clark Street
    Suite 750
    Chicago � IL � 60603
    Class A01/07/2025413441879.49

    144: Remarks and Signature

    Remarks
    Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
    Date of Notice
    03/03/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Bradley Herring

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ENFN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    OPENLANE Names Brad Herring Chief Financial Officer

    Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

    4/22/25 4:15:00 PM ET
    $ENFN
    $FOUR
    $KAR
    Computer Software: Prepackaged Software
    Technology
    Real Estate
    Retail-Auto Dealers and Gas Stations

    Clearwater Analytics Finalizes Acquisition of Enfusion

    Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

    4/21/25 4:15:00 PM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

    Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

    4/17/25 8:00:00 AM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    SEC Filings

    View All

    SEC Form 15-12G filed by Enfusion Inc.

    15-12G - Enfusion, Inc. (0001868912) (Filer)

    5/1/25 4:15:29 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    SEC Form EFFECT filed by Enfusion Inc.

    EFFECT - Enfusion, Inc. (0001868912) (Filer)

    4/24/25 12:15:09 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    SEC Form POS AM filed by Enfusion Inc.

    POS AM - Enfusion, Inc. (0001868912) (Filer)

    4/21/25 4:57:41 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/23/25 4:30:12 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/23/25 4:30:09 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Enfusion, Inc. (0001868912) (Issuer)

    4/21/25 5:11:16 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley resumed coverage on Enfusion with a new price target

    Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

    5/10/24 8:40:24 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion downgraded by Goldman with a new price target

    Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

    2/28/24 6:16:11 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion downgraded by JP Morgan with a new price target

    JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

    1/30/24 6:55:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Leadership Updates

    Live Leadership Updates

    View All

    FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

    FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

    10/29/24 7:00:00 AM ET
    $ENFN
    $GLOB
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

    Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

    10/10/24 9:00:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

    Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

    9/23/24 8:00:00 AM ET
    $ENFN
    $GLOB
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    $ENFN
    Financials

    Live finance-specific insights

    View All

    Clearwater Analytics Finalizes Acquisition of Enfusion

    Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

    4/21/25 4:15:00 PM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Enfusion Announces Fourth Quarter and Full Year 2024 Results

    Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $36.9 million with an Adjusted Gross Profit Margin of 69.6%. Net Income was $0.2 million with a Net Income Margin of 0.3%. Adjusted EBITDA was $12.3 million, up 25.3% compared to the same period in the prior year. Operating Cash Fl

    3/3/25 4:05:00 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

    Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features multimedia. View the full release here: https

    1/13/25 6:30:00 AM ET
    $CWAN
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    10/29/24 7:13:25 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    10/25/24 4:30:55 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

    SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

    9/6/24 3:32:03 PM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology